XML 54 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Tables)
12 Months Ended
Jun. 30, 2020
Stockholders' Equity [Abstract]  
Schedule Of Option Activity

Options

Weighted
Average
Exercise
Price

Weighted
Average
Remaining
Contractual
Term in Years

Outstanding at beginning of period

1,260 

$

72.91 

4.4

Granted

162 

146.34 

Exercised

(350)

57.17 

Forfeited

(4)

110.19 

Outstanding at end of period

1,068 

$

89.05 

4.4

Options exercisable at end of period

641 

$

71.18 

3.7

Options vested and expected to vest at end of period

1,046 

$

88.32 

4.4

Schedule Of Activity Of Restricted Stock Units

Restricted
Stock
Units

Weighted
Average
Grant-Date
Fair Value

Weighted
Average
Remaining
Contractual
Term in Years

Outstanding at beginning of period

1,446 

$

77.21 

1.6

Granted

363 

141.00 

Vested*

(929)

61.13 

Performance factor adjustment

294 

-

Expired / cancelled

(37)

91.66 

Forfeited

(5)

91.66 

Outstanding at end of period

1,132 

$

103.77 

1.6

* Includes 312 thousand shares netted for tax.

Schedule Of Assumptions For Fair Value Of Stock Option Plans And Purchase Rights Granted

2020

2019

2018

Stock options:

Weighted average grant date fair value

$

32.14

$

21.92

$

16.68

Weighted average risk-free interest rate

1.58%

2.96%

2.08%

Expected life in years

4.9

4.9

4.9

Dividend yield

1.07%

1.34% - 1.46%

1.46% - 1.65%

Expected volatility

25%

23%

23%

ESPP purchase rights:

Weighted average grant date fair value

$

31.82

$

22.12

$

17.44

Weighted average risk-free interest rate

1.6%

2.4%

0.8%

Expected life in years

6 months

6 months

6 months

Dividend yield

0.98% - 1.42%

1.40% - 1.47%

1.47% - 1.92%

Expected volatility

23% - 60%

23%

23%

Schedule Of Total Stock-Based Compensation Costs Incurred And Associated Tax Benefit Recognized

2020

2019

2018

Cost of sales - capitalized as part of inventory

$

3,703 

$

3,043 

$

2,990 

Selling, general and administrative expenses

47,265 

42,700 

39,754 

Research and development expenses

6,591 

6,330 

5,668 

Stock-based compensation costs

57,559 

52,073 

48,412 

Tax benefit

(39,534)

(26,658)

(17,078)

Stock-based compensation costs, net of tax benefit

$

18,025 

$

25,415 

$

31,334